Establishment and Application of a Multiple Cross Displacement Amplification Coupled With Nanoparticle-Based Lateral Flow Biosensor Assay for Detection of
Overview
Infectious Diseases
Microbiology
Authors
Affiliations
() is responsible for pneumonia, and is a causative agent of other respiratory tract infections (e.g., bronchiolitis and tracheobronchitis). Herein, we established and applied a multiple cross displacement amplification (MCDA) coupled with a nanoparticle-based lateral flow biosensor (LFB) assay (MCDA-LFB) for rapid, simple, and reliable detection of target pathogen. A set of 10 primers was designed based on -specific P1 gene, and optimal reaction conditions were found to be 30 min at 65°C. The detection results were visually reported using a biosensor within 2 min. The -MCDA-LFB method specifically detected only templates, and no cross-reactivity was generated from non- isolates. The analytical sensitivity for this assay was 50 fg of genomic templates in the pure cultures, as obtained from colorimetric indicator and real-time turbidimeter analysis. The assay was applied to 197 oropharyngeal swab samples collected from children highly suspected of infection, and compared to culture-based method and real-time PCR assay. The detection rates of using a culture-based method, real-time PCR assay, and MCDA-LFB assay were 8.1%, 33.0%, and 52.3%, respectively, which indicated that the MCDA-LFB assay was superior to the culture-based method and real-time PCR method for detection of target agent. Using this protocol, 25 min for rapid template extraction followed by MCDA reaction (30 min) combined with LFB detection (2 min) resulted in a total assay time of ~60 min. In conclusion, the MCDA-LFB assay established in this report was a simple, rapid, sensitive, and reliable assay to detect strains, and can be used as a potential diagnostic tool for in basic and clinical laboratories.
An accurate and convenient method for via one-step LAMP-CRISPR/Cas12b detection platform.
Liu T, Liu Q, Chen F, Shi Y, Maimaiti G, Yang Z Front Cell Infect Microbiol. 2024; 14:1409078.
PMID: 39176261 PMC: 11338869. DOI: 10.3389/fcimb.2024.1409078.
Laboratory diagnosis and treatment of infection in children: a review.
Gao L, Sun Y Ann Med. 2024; 56(1):2386636.
PMID: 39097794 PMC: 11299444. DOI: 10.1080/07853890.2024.2386636.
Sun C, Wang C, Xiao F, Jia N, Huang X, Fu J Heliyon. 2024; 10(11):e31901.
PMID: 38845879 PMC: 11154602. DOI: 10.1016/j.heliyon.2024.e31901.
Silva M, Souza K, Bezerra T, Silva T, Fernades D, Silva F Braz J Med Biol Res. 2023; 56:e12894.
PMID: 37851790 PMC: 10578128. DOI: 10.1590/1414-431X2023e12894.
Rapid, ultrasensitive and highly specific diagnosis of by a CRISPR-based detection platform.
Zhou J, Xiao F, Fu J, Jia N, Huang X, Sun C Front Cell Infect Microbiol. 2023; 13:1147142.
PMID: 37577370 PMC: 10414563. DOI: 10.3389/fcimb.2023.1147142.